We are live on ! Find out more
JSSH

J. Safra Sarasin Holding Portfolio holdings

AUM $6.97B
1-Year Est. Return 32.91%
This Fund
S&P 500
This Quarter Est. Return
+2.18%
1 Year Est. Return
+32.91%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.91B
AUM Growth
+$152M
Cap. Flow
+$172M
Cap. Flow %
2.9%
Top 10 Hldgs %
26.47%
Holding
518
New
75
Increased
153
Reduced
181
Closed
55

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$69.9M
2
BKR icon
Baker Hughes
BKR
+$47.9M
3
TSLA icon
Tesla
TSLA
+$37.8M
4
WMT icon
Walmart Inc
WMT
+$33.2M
5
TT icon
Trane Technologies
TT
+$25M

Sector Composition

Rank Sector Weight
1 Technology 31.02%
2 Consumer Discretionary 12.78%
3 Industrials 12.37%
4 Financials 11.99%
5 Healthcare 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRT icon
301
Copart
CPRT
$26.8B
$1.13M 0.02%
19,648
+925
+5% +$52.7K
CWEN icon
302
Clearway Energy Class C
CWEN
$7.01B
$1.12M 0.02%
+42,923
New +$1.19M
FDS icon
303
Factset
FDS
$9.85B
$1.09M 0.02%
2,275
-287
-11% -$136K
XLU icon
304
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
$1.08M 0.02%
28,480
+9,000
+46% +$357K
CHD icon
305
Church & Dwight Co
CHD
$24.2B
$1.08M 0.02%
10,287
+897
+10% +$94.6K
CFG icon
306
Citizens Financial Group
CFG
$31B
$1.07M 0.02%
24,559
-20,006
-45% -$885K
BR icon
307
Broadridge
BR
$19.2B
$1.07M 0.02%
+4,750
New +$1.06M
CEG icon
308
Constellation Energy
CEG
$99B
$1.06M 0.02%
+4,740
New +$1.18M
MSCI icon
309
MSCI
MSCI
$40.7B
$1.06M 0.02%
+1,762
New +$1.06M
ACN icon
310
Accenture
ACN
$109B
$1.06M 0.02%
3,000
-524
-15% -$189K
BERY
311
DELISTED
Berry Global Group, Inc.
BERY
$1.05M 0.02%
16,306
-1,451
-8% -$95.8K
MANH icon
312
Manhattan Associates
MANH
$11.1B
$1.05M 0.02%
3,892
-841
-18% -$240K
PAYX icon
313
Paychex
PAYX
$42.5B
$1.05M 0.02%
7,498
-865
-10% -$123K
MDGL icon
314
Madrigal Pharmaceuticals
MDGL
$12.4B
$1.05M 0.02%
3,405
-2,195
-39% -$617K
WST icon
315
West Pharmaceutical
WST
$24.8B
$1.05M 0.02%
3,206
-7,952
-71% -$2.5M
BMY icon
316
Bristol-Myers Squibb
BMY
$130B
$1.05M 0.02%
18,533
-17,940
-49% -$1M
VRSK icon
317
Verisk Analytics
VRSK
$23.5B
$1.05M 0.02%
3,795
-136
-3% -$37.8K
GGG icon
318
Graco
GGG
$13.3B
$1.04M 0.02%
12,397
-600
-5% -$52K
MAA icon
319
Mid-America Apartment Communities
MAA
$15.4B
$1.04M 0.02%
6,722
-843
-11% -$132K
IBIT icon
320
iShares Bitcoin Trust
IBIT
$47.2B
$1.04M 0.02%
+19,548
New +$923K
CLX icon
321
Clorox
CLX
$12.8B
$1.04M 0.02%
+6,385
New +$1.04M
AVB icon
322
AvalonBay Communities
AVB
$25.8B
$1.03M 0.02%
4,702
-505
-10% -$114K
IDXX icon
323
Idexx Laboratories
IDXX
$45B
$1.03M 0.02%
2,493
+426
+21% +$187K
FICO icon
324
Fair Isaac
FICO
$22.3B
$1.03M 0.02%
+517
New +$1.1M
VEEV icon
325
Veeva Systems
VEEV
$38.8B
$1.02M 0.02%
4,875
-798
-14% -$176K

Similar funds

J. Safra Sarasin Holding's Q4 2024 Portfolio in Review

As of Q4 2024, J. Safra Sarasin Holding held 518 positions worth $5.91B, up 2.6% from $5.76B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

J. Safra Sarasin Holding's Q4 2024 filing shows 75 new, 153 increased, 181 reduced and 55 closed positions. Its largest new stake was iShares US Healthcare ETF: 166,180 shares worth $9.68M. The largest sale was Alphabet (Google) Class A, an estimated $35.4M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • J. Safra Sarasin Holding's largest Q4 2024 buy was iShares US Healthcare ETF: 166,180 shares worth $9.68M.
  • J. Safra Sarasin Holding added most to UBS Group in Q4 2024, an estimated $69.9M increase.
  • J. Safra Sarasin Holding's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $35.4M.
  • J. Safra Sarasin Holding fully exited Global Payments in Q4 2024, selling an estimated $12.3M.
  • J. Safra Sarasin Holding's ten largest holdings make up 26% of its $5.91B portfolio in Q4 2024.
  • J. Safra Sarasin Holding opened 75 new positions and closed 55 in Q4 2024.
  • J. Safra Sarasin Holding's portfolio value rose 2.6% quarter-over-quarter to $5.91B.

Based on J. Safra Sarasin Holding's 13F filing for Q4 2024, filed 14 Feb 2025.